Probiotics, prebiotics and symbiotics in inflammatory bowel diseases: state-of-the-art and new insights

Mario Cottone, Antonino Abbruzzo, Vincenzo Davide Palumbo, Giovanni Tomasello, Giuseppe Damiano, Angelo Leone, Emanuele Sinagra, Francesco Damiani, Attilio Ignazio Lo Monte, Francesco Cappello, Dario Raimondo, Maurizio Bellavia, Provvidenza Damiani, Zeenny, Emanuele Sinagra, Massimo Cocchi, Francesca Rossi, Tomasello, Facella, JurjusCappello, Gabriele Spinelli

Risultato della ricerca: Article

21 Citazioni (Scopus)

Abstract

Inflammatory bowel disease (IBD) consists of two distinct clinical forms, ulcerative colitis (UC) and Crohn s disease (CD), with unknown aetiology, which nevertheless are considered to share almost identical pathophysiological backgrounds. Up to date, a full coherent mechanistic explanation for IBD is still lacking, but people start to realize that the pathogenesis of IBD involves four fundamental components: the environment, gut microbiota, the immune system and the genome. As a consequence, IBD development might be due to an altered immune response and a disrupted mechanism of host tolerance to the non-pathogenic resident microbiota, leading to an elevated inflammatory response. Considering the available data arising from the scientific literature, here reviewed, in CD, a benefit of probiotics remains unproven; in UC, a benefit of probiotics remains unproven, even if E. coli Nissle 1917seems promising in maintaining remission and it could be considered an alternative in patients intolerant or resistant to 5-ASA preparations; in pouchitis, small controlled trials suggest a benefit from VSL no. 3 in the primary and secondary prevention of pouchitis; in IBD-associated conditions, a benefit of probiotics remains unproven. However, well-designed randomized control clinical trials are necessary to understand the undoubted role of these agents in the management of gut physiology in health and disease.
Lingua originaleEnglish
pagine (da-a)919-933
Numero di pagine15
RivistaJOURNAL OF BIOLOGICAL REGULATORS & HOMEOSTATIC AGENTS
Volume27
Stato di pubblicazionePublished - 2013

All Science Journal Classification (ASJC) codes

  • Endocrinology, Diabetes and Metabolism
  • Immunology and Allergy
  • Physiology
  • Immunology
  • Oncology
  • Endocrinology
  • Physiology (medical)
  • Cancer Research

Fingerprint Entra nei temi di ricerca di 'Probiotics, prebiotics and symbiotics in inflammatory bowel diseases: state-of-the-art and new insights'. Insieme formano una fingerprint unica.

  • Cita questo